3D Techniques (NYSE: DDD) has reported its monetary outcomes for the second quarter of 2025, displaying a drop in income however a pointy enchancment in profitability, pushed by price reductions, effectivity positive factors, and robust efficiency in key markets.
Income Down, However Margins Enhance
The corporate posted income of $94.8 million for the quarter ending June 30, 2025, a 16% drop in comparison with the $113.3 million recorded in the identical interval final yr. Healthcare Options — which incorporates medical and dental 3D printing merchandise, supplies, and providers — fell 8% to $45 million. The decline was primarily as a result of weaker demand within the dental section, particularly from prospects within the aligner market.
In the meantime, its Industrial Options section — overlaying 3D printing methods, supplies, and providers for aerospace, protection, automotive, and different manufacturing sectors — dropped 23% to $49.8 million, pointing to decreased capital spending in markets that promote on to shoppers.
Along with the gross sales decline, gross revenue margin was 38.1%, down barely from 41.6% a yr earlier. On an adjusted foundation, it was 39.2%. The corporate mentioned the decline was partly as a result of a much less favorable product combine following the sale of its Geomagic software program enterprise earlier within the quarter.
Slicing Prices Pays Off
3D Techniques reported internet earnings of $104.4 million, a significant turnaround from a $27.3 million loss in Q2 2024. This variation was the results of stronger operations, a $125.7 million pre‑tax acquire from promoting the Geomagic enterprise, and an $8.2 million acquire from repurchasing debt at a reduction.
Late within the quarter, the corporate made main modifications to its funds. It paid off $88 million in debt, pushed most of its remaining debt funds out to 2030, and acquired again 8 million shares to provide current shareholders a bigger stake within the firm. CEO Jeffrey Graves known as this a “steadiness sheet transformation” that can assist assist future development.
Working bills fell to $51.5 million from $73.5 million final yr, because of restructuring strikes introduced in March. These included consolidating operations, chopping workforce prices, and different effectivity packages. The corporate mentioned it saved over $20 million in working bills throughout the quarter and expects the cost-cutting plan to proceed into mid-2026.
Graves mentioned, “We’re benefiting from our prior efforts to completely in-source manufacturing and provide chain operations, an initiative which is now nearly full and serving to to offset headwinds from tariffs. Within the second quarter, tariffs elevated our prices by roughly $1 million, however had been largely countered by improved working efficiencies in manufacturing operations, which supported our gross margin efficiency.”
Jeffrey Graves speaks at AMS 2025. Picture courtesy of 3DPrint.com.
Combined Market Efficiency
So, whereas general income was down, some areas confirmed sturdy development. Medical Expertise gross sales, particularly in orthopedic procedures and trauma-related surgical procedures, rose 13% year-over-year and 16% from the earlier quarter. Aerospace and Protection gross sales jumped 84% in comparison with Q2 2024 and 53% from Q1 2025, now producing over $30 million yearly.
“For our industrial prospects, whereas consumer-facing markets had been weak, we skilled sturdy demand in Aerospace & Protection, with revenues rising 84% from the prior yr, and 53% sequentially from the primary quarter,” defined Graves. “Central to our development in A&D is our distinctive capacity to fulfill prospects’ wants from the inception of course of growth, by preliminary half manufacturing, and finally to full-scale printer provide when demand rises. We’re the one US supplier of 3D printing applied sciences that may supply this full spectrum of functionality, and accomplish that over your entire breadth of polymer and metallic printing applied sciences. Furthermore, we will do that regionally throughout the US and inside EMEA for industrial prospects needing high-reliability parts. Because of this, we’re enthusiastic about our future development in these markets that demand the best element reliability, similar to Aerospace & Protection, AI infrastructure, and Oil & Fuel, to call a number of.”
In the meantime, the dental enterprise was down 3% for the quarter, with aligner market demand falling 19% sequentially. That is in keeping with a broader slowdown within the aligner market, as Align Expertise (the maker of Invisalign) additionally lately reported a softening in demand in its Q2 earnings. Client-related industrial gross sales additionally suffered from weaker buyer capital spending, which 3D Techniques attributed to uncertainty round tariffs.
Strategic Strikes
The corporate highlighted a milestone in its long-term partnership with United Therapeutics, which goals to develop 3D printed human lungs for transplant. The venture, a part of United Therapeutics’ broader regenerative drugs program, reached a brand new printing benchmark for human lung scaffolds within the quarter, leading to a $2 million award for 3D Techniques.
In current months, 3D Techniques has seen a number of modifications in its bioprinting segments. The corporate closed its Systemic Bio subsidiary, which had centered on production-scale bioprinted tissue fashions. Taci Pereira, who led Systemic Bio, has since left the corporate and is now CEO of BALSA, a nonprofit group devoted to empowering the neighborhood of Brazilians in life sciences within the U.S. Regardless of the closure, 3D Techniques stays lively in bioprinting by its Allevi subsidiary and its ongoing work with United Therapeutics.
3D Techniques creates implantable medical units. Picture courtesy of 3D Techniques.
On the finish of June, the corporate had $116.4 million in money and money equivalents, down from $171.3 million on the finish of 2024. The drop was primarily as a result of $59.6 million utilized in operations and $97.3 million utilized in financing actions, partially offset by $112.9 million from investing actions.
3D Techniques expects its price financial savings program, debt restructuring, and deal with high-growth markets like medical know-how and aerospace to assist return the corporate to optimistic money stream in 2026. Nonetheless, administration warned that tariffs will probably proceed to impression prices within the second half of the yr. As well as, the corporate mentioned it is not going to present detailed forecasts for sure measures, citing the “unpredictability of things similar to litigation prices, acquisitions, restructuring costs, and different gadgets that might materially have an effect on outcomes.”
Subscribe to Our E mail E-newsletter
Keep up-to-date on all the newest information from the 3D printing trade and obtain info and gives from third celebration distributors.
Add your 3D Fashions and get them printed shortly and effectively.
